OKYO Pharma Files for Fast Track Designation with FDA for Urcosimod to Treat Neuropathic Corneal Pain
OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative therapies for the ...
Everyday Health on MSN6d
7 Things to Avoid if You Have Thyroid Eye Disease
Smoking, poor diet, stress, and other factors can worsen symptoms; here's what to know to maintain eye health and slow ...
technologynetworks29d
Stem Cell Shots Unveil a Safer Way To Treat Inflammatory Eye Diseases
Inflammatory eye diseases can be challenging to treat, with medications like corticosteroids causing unwanted complications such as glaucoma. However, a study led by researchers from Fujita Health ...
Medscape23d
Etanercept (enbrel)-associated inflammatory eye disease: case report and review of the literature.
Seventeen cases of inflammatory eye disease (uveitis, scleritis, orbital myositis) believed to be associated with etanercept therapy were found in the recent literature. CONCLUSIONS: Ocular ...
Medscape4mon
Cornea and External Disease News
Medscape Medical News, December 11, 2024 Hidradenitis Suppurativa Linked to Inflammatory Eye Disease Among 355 patients with HS included in the systematic review, about 22% had inflammatory eye ...
Hosted on MSN28d
Stem cell shots: Unveiling a safer way to treat inflammatory eye diseases
Using mice that had been induced with chronic GVHD, researchers administered adMSCs into the eyes via a single ... chronic ocular GVHD and related inflammatory diseases. Future studies, however ...
Ophthalmology Times12h
OKYO Pharma files application for Fast Track designation with the FDA for urcosimod for the treatment of neuropathic corneal pain
Urcosmid is a lipid conjugated chemerin peptide agonist of the ChemR23 G-protein coupled receptor, typically found on immune ...